Status: Recruiting
Perivenous Dexamethasone Therapy: Examining Reduction of Inflammation After Thrombus Removal to Yield Benefit in Acute Femoropopliteal DVT
This is a study of a medical procedure that utilizes a commercially available catheter (the Bullfrog® Micro-Infusion Device) to locally deliver a commercially available anti-inflammatory drug (dexamethasone sodium phosphate injection) around the deep veins after DVT recanalization, where DVT symptoms were present for up to 14 days prior to recanalization. The goal of the study is to see if local anti-inflammation helps prevent re-thrombosis of the blood vessel and improvement in symptoms for up to 24 months after the initial DVT recanalization procedure.
Participants needed: 80
Trial details
Phase: Phase 2Age: 18-89Biological sex: AllType: InterventionalSponsor: Mercator MedSystems, Inc.Updated: Jul 4, 2025Locations: 17
Eligibility criteria
Provision of signed and dated informed consent form prior to receiving any non-s... [+9]
Current enrollment in another non-registry clinical study of systemic drug thera... [+33]